KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Gains from Investment Securities (2018 - 2025)

ClearPoint Neuro's Gains from Investment Securities history spans 13 years, with the latest figure at -$2.9 million for Q3 2025.

  • For Q3 2025, Gains from Investment Securities fell 4926.23% year-over-year to -$2.9 million; the TTM value through Sep 2025 reached $1.7 million, up 547.37%, while the annual FY2024 figure was $1.4 million, 555.43% up from the prior year.
  • Gains from Investment Securities for Q3 2025 was -$2.9 million at ClearPoint Neuro, down from $3.3 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $3.3 million in Q2 2025 and bottomed at -$2.9 million in Q3 2025.
  • The 5-year median for Gains from Investment Securities is $59000.0 (2021), against an average of $408058.1.
  • The largest YoY upside for Gains from Investment Securities was 14796.4% in 2025 against a maximum downside of 4926.23% in 2025.
  • A 5-year view of Gains from Investment Securities shows it stood at $57000.0 in 2021, then surged by 489.47% to $336000.0 in 2022, then tumbled by 88.99% to $37000.0 in 2023, then surged by 3619.99% to $1.4 million in 2024, then plummeted by 313.89% to -$2.9 million in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Gains from Investment Securities are -$2.9 million (Q3 2025), $3.3 million (Q2 2025), and $1.3 million (Q1 2025).